Author + information
- Rahul S. Loungani, MDa,∗ (, )@rsloungani,
- Sitharthan Sekar, MDb,
- Michael R. Rehorn, MD, MSa,
- Eric Black-Maier, MDa,
- Sreekanth Vemulapalli, MDa,
- Svati H. Shah, MD, MHSa and
- Robert W. Harrison, MDa
- aDivision of Cardiology, Duke University School of Medicine, Durham, North Carolina
- bDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina
- ↵∗Address for correspondence:
Dr. Rahul S. Loungani, Duke University Medical Center, 2301 Erwin Road, DUMC 3845, Durham, North Carolina 27710.
A 69-year-old man with a history of coronary artery ectasia, potentially resulting from an underlying heritable connective tissue disorder, presented with ventricular fibrillation. Despite medical management of ischemia, he developed recurrent ventricular tachycardia with poor neurological recovery. We highlight challenges in the management of coronary artery ectasia. (Level of Difficulty: Beginner.)
Drs. Loungani and Rehorn have received research support from Pfizer and Boston Scientific. Dr. Black-Maier has received research support from Boston Scientific. Dr. Vemulapalli has received support from Abbott Vascular, Boston Scientific, National Institutes of Health, Patient Centered Outcomes Research Institute, FDA (Nest), American College of Cardiology, and The Society of Thoracic Surgeons; and serves on advisory boards for Janssen, Boston Scientific, and HeartFlow All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Case Reports author instructions page.
- Received June 4, 2020.
- Accepted June 17, 2020.
- 2020 The Authors